FINAL PROGR AM - American Society of Gene & Cell Therapy
FINAL PROGR AM - American Society of Gene & Cell Therapy
FINAL PROGR AM - American Society of Gene & Cell Therapy
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>AM</strong>ERICAN SOCIETY OF GENE THERAPY • Final Program 153<br />
EXHIBITOR DESCRIPTIONS<br />
Open Biosystems<br />
6705 Odyssey Dr.<br />
Huntsville, AL 35806<br />
Phone: 888-412-2225<br />
Fax: 256-704-4849<br />
E-Mail: info@openbiosystems.com<br />
www.openbiosystems.com<br />
Booth Number: 210<br />
Open Biosystems is dedicated to distributing high-quality<br />
tools to unlock the functions <strong>of</strong> human genes and their<br />
relationships to disease development. We <strong>of</strong>fer products<br />
for genomic and proteomic research from shRNA<br />
libraries and cDNA clones to custom peptide and<br />
antibody production services.<br />
Pall Life Sciences<br />
2200 Northern Blvd.<br />
East Hills, NY 11548<br />
Phone: 516-484-3600<br />
Fax: 516-484-3649<br />
E-Mail: cdellicicchi@pall.com<br />
www.pall.com<br />
Booth Number: 308<br />
Pall <strong>of</strong>fers process filtration, separation and purification<br />
development, pilot and manufacturing equipment and<br />
validation services together with pre-inspection reviews,<br />
troubleshooting consultancy, training, contamination<br />
analysis and other technical assistance. We <strong>of</strong>fer protein<br />
expression monitoring and multi-step chromatography<br />
purification development, target and impurity tracking<br />
and host cell protein assay development, purification<br />
optimization and custom affinity sorbents.<br />
PolyPlus - Transfection<br />
Bioparc BP 90018<br />
Illkirch 67401<br />
FRANCE<br />
Phone: 33-03-90-40-61-85<br />
Fax: 33-03-90-40-61-81<br />
E-Mail: pbelguise@polyplus-transfection.com<br />
www.polyplus-transfection.com<br />
Booth Number: 515<br />
Polyplus-transfection is a French Life Science company<br />
dedicated to the development and marketing <strong>of</strong> transfection<br />
reagents. Polyplus key transfection reagents are<br />
jetPEI for DNA and oligonucleotides in vitro and in vivo<br />
delivery (cGMP available), jetSI-ENDO for siRNA<br />
delivery and Fecturin for protein production in synthetic<br />
media.<br />
Puresyn, Inc.<br />
87 Great Valley Parkway<br />
Malvern, PA 19355<br />
Phone: 610-640-0800<br />
Fax: 610-640-0808<br />
E-Mail: leslie@puresyn.com<br />
www.puresyn.com<br />
Booth Number: 209<br />
Puresyn, Inc. is a Separations and Purification Technology<br />
Company that develops,<br />
manufactures and markets state-<strong>of</strong>-the-art products and<br />
services for the separation and purification <strong>of</strong> nucleic<br />
acids and other biological molecules utilizing its proprietary<br />
polymer technology, PolyFlo ® , an inert, irregularly<br />
shaped, non-porous polymer resin. The Company is a<br />
leading supplier <strong>of</strong> contract manufacturing services for<br />
production and purification <strong>of</strong> plasmid and viral vectorbased<br />
gene therapies at scales and specifications suitable<br />
for research, development and pre-clinical requirements.<br />
Puresyn has also introduced two (2) new Adenovirus<br />
purification kits, ADENOPURE Ò and ADENOPURE<br />
LS ä . They replace time and labor intensive double cesium<br />
chloride gradient and generate adenovirus preparations<br />
with high purity and potency in a convenient kit format.<br />
Rheo<strong>Gene</strong> Inc.<br />
2650 Eisenhower Avenue<br />
Norristown, PA 19403<br />
Phone: 610-650-8734<br />
Fax: 610-650-8755<br />
www.rheogene.com<br />
Booth Number: 213<br />
Rheo<strong>Gene</strong> is developing its proprietary RheoSwitch®<br />
Therapeutic System for safe, targeted and regulated cell<br />
and gene therapies that deliver the right dose- to the right<br />
place- at the right time- to improve the lives <strong>of</strong> patients<br />
with serious medical conditions for which there are no<br />
effective treatments or cures.<br />
Sangamo BioSciences, Inc.<br />
501 Canal Boulevard, Suite A100<br />
Richmond, CA 94804<br />
Phone: 510-970-6000<br />
Fax: 510-236-8951<br />
E-Mail: erhodes@sangamo.com<br />
www.sangamo.com<br />
Booth Number: 214-216<br />
Sangamo Biosciences, Inc is focused on the research and<br />
development <strong>of</strong> zinc finger DNA binding proteins<br />
(ZFPs) for therapeutic gene regulation and repair. The<br />
company’s most advanced clinical program is for treatment<br />
<strong>of</strong> diabetic neuropathy. Sangamo has additional<br />
programs in cardiovascular disease, neuropathic pain,<br />
<strong>AM</strong>D, and HIV.